SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001599298-20-000043
Filing Date
2020-11-16
Accepted
2020-11-16 16:13:32
Documents
59
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q smmt-20200930.htm   iXBRL 10-Q 998006
2 EX-31.1 exhibit311.htm EX-31.1 11496
3 EX-31.2 exhibit312.htm EX-31.2 11517
4 EX-32.1 exhibit321.htm EX-32.1 7104
  Complete submission text file 0001599298-20-000043.txt   4561492

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20200930.xsd EX-101.SCH 34733
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20200930_cal.xml EX-101.CAL 59063
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20200930_def.xml EX-101.DEF 151339
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20200930_lab.xml EX-101.LAB 426025
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20200930_pre.xml EX-101.PRE 272967
10 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20200930_htm.xml XML 674607
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36866 | Film No.: 201317004
SIC: 2834 Pharmaceutical Preparations